Methyl aminolevulinate

Methyl aminolevulinate (MAL) is a topical cream used to treat actinic keratoses (AKs). AKs are precancerous skin growths caused by sun damage. MAL is a form of a naturally occurring chemical in the body called porphyrin. When applied to the skin, it is absorbed by the abnormal AK cells and converted into a form of light-sensitive molecule. When exposed to a special type of light, the abnormal cells are destroyed. This treatment is known as photodynamic therapy (PDT). MAL is the only approved topical treatment for AKs and is typically used in combination with PDT.

Methyl aminolevulinate (MAL) functions as a prodrug in the context of medicine. Here's a breakdown of its key aspects:

Mechanism of action:

  • Prodrug: MAL itself is not directly active. It needs to be converted within the body into another substance to exert its medicinal effect.
  • Conversion: After topical application, MAL gets metabolized into protoporphyrin IX (PpIX), a photosensitive molecule.

Medical use:

  • Photodynamic therapy (PDT): MAL is primarily used in conjunction with PDT to treat specific skin conditions.
  • Target: PpIX accumulated in the applied area becomes sensitive to light.
  • Light activation: During PDT, a specific wavelength of light is shone on the treated area. This light activates the PpIX molecules.
  • Cell destruction: Activated PpIX triggers the production of reactive oxygen species, which damage and destroy targeted cells.

Applications in PDT:

  • Actinic keratosis (AK): A precancerous condition characterized by rough, scaly patches on the skin, primarily caused by sun exposure.
  • Basal cell carcinoma (BCC): A slow-growing type of skin cancer.

Important points to remember:

  • Prescription medication: MAL is only available as a prescription cream and should be administered by a healthcare professional.
  • Light source: The type of light used during PDT varies depending on the targeted condition and needs to be precisely controlled.
  • Limited applications: MAL-PDT is not a suitable treatment for all skin cancers.

Disclaimer:

  • I am not a medical professional and this information should not be interpreted as medical advice.

Additional considerations:

  • Side effects: Potential side effects associated with MAL-PDT include:
    • Skin irritation and redness
    • Pain or burning sensation at the treatment site
    • Swelling
    • Crusting
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01X - Other antineoplastic agents
L01XD Sensitizers used in photodynamic/radiation therapy
External Links